Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor
- PMID: 10893213
- DOI: 10.1152/ajplung.2000.279.1.L143
Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor
Abstract
Angiotensin-converting enzyme is involved in apoptosis of alveolar epithelial cells (Wang R, Zagariya A, Ang E, Ibarra-Sunga O, and Uhal BD. Am J Physiol Lung Cell Mol Physiol 277: L1245-L1250, 1999). This study tested the ability of the angiotensin-converting enzyme inhibitor captopril or the caspase inhibitor Z-Val-Ala-Asp-fluoromethylketone (ZVAD-fmk) to block alveolar epithelial cell apoptosis and lung fibrosis in vivo in response to bleomycin (Bleo). Male Wistar rats received 8 U/kg of Bleo (bleomycin sulfate) or vehicle intratracheally. Subgroups of Bleo-treated rats received captopril, ZVAD-fmk, or vehicle alone. Lung collagen was assessed by picrosirius red or hydroxyproline assay at 1, 7, and 14 days post-Bleo, and apoptosis was detected by in situ end labeling (ISEL). Bleo increased alveolar septal and peribronchial collagen by 100 and 133%, respectively (both P < 0.01), by day 14 but not earlier. In contrast, ISEL was increased in alveolar and airway cells at all time points. Captopril or ZVAD-fmk inhibited collagen accumulation by 91 and 85%, respectively (P < 0. 01). Both agents also inhibited ISEL in alveoli by 99 and 81% and in airways by 67 and 63%, respectively. These data suggest that the efficacy of captopril to inhibit experimental lung fibrogenesis is related to inhibition of apoptosis. They also demonstrate the antifibrotic potential of a caspase inhibitor.
Similar articles
-
Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro.Am J Physiol Lung Cell Mol Physiol. 2000 May;278(5):L1039-44. doi: 10.1152/ajplung.2000.278.5.L1039. Am J Physiol Lung Cell Mol Physiol. 2000. PMID: 10781436
-
Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists.Pharmacol Toxicol. 2003 Feb;92(2):81-7. doi: 10.1034/j.1600-0773.2003.920204.x. Pharmacol Toxicol. 2003. PMID: 12747577
-
Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction.Am J Physiol. 1999 Dec;277(6):L1245-50. doi: 10.1152/ajplung.1999.277.6.L1245. Am J Physiol. 1999. PMID: 10600897
-
Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo.Am J Physiol Lung Cell Mol Physiol. 2003 Mar;284(3):L501-7. doi: 10.1152/ajplung.00273.2002. Epub 2002 Nov 15. Am J Physiol Lung Cell Mol Physiol. 2003. PMID: 12573988
-
Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.Am J Pathol. 2003 Dec;163(6):2523-30. doi: 10.1016/S0002-9440(10)63607-3. Am J Pathol. 2003. PMID: 14633624 Free PMC article.
Cited by
-
Lung fibrogenic microenvironment in mouse reconstitutes human alveolar structure and lung tumor.iScience. 2022 Aug 11;25(9):104912. doi: 10.1016/j.isci.2022.104912. eCollection 2022 Sep 16. iScience. 2022. PMID: 36060050 Free PMC article.
-
Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.Ann Med. 2015 Mar;47(2):100-5. doi: 10.3109/07853890.2014.991751. Epub 2015 Jan 22. Ann Med. 2015. PMID: 25613169 Free PMC article. Review.
-
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.Treat Respir Med. 2006;5(5):325-42. doi: 10.2165/00151829-200605050-00004. Treat Respir Med. 2006. PMID: 16928146 Free PMC article. Review.
-
Interstitial lung disease in lung cancer: separating disease progression from treatment effects.Drug Saf. 2005;28(2):103-13. doi: 10.2165/00002018-200528020-00002. Drug Saf. 2005. PMID: 15691221 Review.
-
Paracrine functions of fibrocytes to promote lung fibrosis.Expert Rev Respir Med. 2014 Apr;8(2):163-72. doi: 10.1586/17476348.2014.862154. Epub 2014 Jan 22. Expert Rev Respir Med. 2014. PMID: 24451025 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous